search
Back to results

Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening

Primary Purpose

Healthy Volunteers

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Decision aid with implicit values clarification method (booklet or website)
Decision aid with explicit values clarification method (booklet or website)
Sponsored by
Universidade do Porto
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Healthy Volunteers

Eligibility Criteria

50 Years - 69 Years (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • adult men (50 - 69 years);
  • men with average risk for prostate cancer;
  • willing and able to provide written informed consent.

Exclusion Criteria:

  • unable to understand written Portuguese.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    No Intervention

    Active Comparator

    Active Comparator

    Arm Label

    decision aid with information only (control)

    decision aid with implicit VCM

    decision aid with explicit VCM

    Arm Description

    decision aid with information only, without values clarification method (VCM)

    decision aid with information plus an implicit VCM

    decision aid with information plus an explicit VCM

    Outcomes

    Primary Outcome Measures

    Perceived clarity of personal values
    3-item subscale of the Decisional Conflict Scale. Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 3; and c) multiplied by 25. Scores range from 0 [feels extremely clear about personal values] to 100 [feels extremely unclear about personal values].

    Secondary Outcome Measures

    Decisional Conflict
    Decisional Conflict Scale (16-item). Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 16; and c) multiplied by 25. Scores range from 0 [no decisional conflict] to 100 [extremely high decisional conflict].
    % of patients with preference to undergo PSA screening (screening intention; questionnaire)
    Intention to undergo prostate cancer screening with PSA: questionnaire - single question about intention to be screened with PSA, using a 5 point-Likert scale (ranging from "strongly disagree" to "strongly agree"; intention to undergo PSA screening will be considered positive if the respondent replies with "agree" or "strongly agree"). % of patients with preference to undergo PSA screening.
    % of patients who underwent PSA screening (questionnaire)
    Self-reported PSA screening. Questionnaire - single question. Men will report wether they have or have not underwent PSA screening after the intervention. % of patients who underwent PSA screening

    Full Information

    First Posted
    June 3, 2019
    Last Updated
    June 14, 2019
    Sponsor
    Universidade do Porto
    Collaborators
    NOVA Medical School, Georgetown University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03988673
    Brief Title
    Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening
    Official Title
    Comparison of Explicit Values Clarification Method (VCM), Implicit VCM and no VCM Decision Aids for Men Considering Prostate Cancer Screening: Protocol of a Randomized Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 2019 (Anticipated)
    Primary Completion Date
    December 2019 (Anticipated)
    Study Completion Date
    September 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Universidade do Porto
    Collaborators
    NOVA Medical School, Georgetown University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The investigators aim at comparing the perceived clarity of personal values in men considering PSA screening using decision aids with no VCM versus an implicit VCM versus an explicit VCM. This study will add to the body of evidence on the role of decision aids to support health preference-sensitive choices and provide further insight on the impact of different methods for eliciting people's values embedded within a decision aid.
    Detailed Description
    PSA test to screen for prostate cancer is considered a preference sensitive decision, meaning it does not only depend on what is best from a medical point of view, but also on patient values. Decision aids are evidence-based tools which showed to help people feel clearer about their values, therefore it has been advocated that decision aids should contain a specific values clarification method (VCM). VCM may be either implicit or explicit but the evidence concerning the best method is scarce. We aim at comparing the perceived clarity of personal values in men considering PSA screening using decision aids with no VCM versus an implicit VCM versus an explicit VCM.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Healthy Volunteers

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Parallel three group (1:1:1): (i) decision aid with information only (Control), (ii) decision aid with information plus an implicit VCM, (iii) decision aid with information plus an explicit VCM.
    Masking
    ParticipantCare ProviderInvestigatorOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    276 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    decision aid with information only (control)
    Arm Type
    No Intervention
    Arm Description
    decision aid with information only, without values clarification method (VCM)
    Arm Title
    decision aid with implicit VCM
    Arm Type
    Active Comparator
    Arm Description
    decision aid with information plus an implicit VCM
    Arm Title
    decision aid with explicit VCM
    Arm Type
    Active Comparator
    Arm Description
    decision aid with information plus an explicit VCM
    Intervention Type
    Other
    Intervention Name(s)
    Decision aid with implicit values clarification method (booklet or website)
    Intervention Description
    The intervention will be an informative evidence-based material in the format of a booklet or website concerning prostate cancer screening. The values clarification method will be a grid where statements about the subject will be presented (decision aid with implicit VCM).
    Intervention Type
    Other
    Intervention Name(s)
    Decision aid with explicit values clarification method (booklet or website)
    Intervention Description
    The intervention will be an informative evidence-based material in the format of a booklet or website concerning prostate cancer screening. The values clarification method will be a a grid where statements about the subject will be presented and men should indicate what statements they identify with (decision aid with explicit VCM).
    Primary Outcome Measure Information:
    Title
    Perceived clarity of personal values
    Description
    3-item subscale of the Decisional Conflict Scale. Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 3; and c) multiplied by 25. Scores range from 0 [feels extremely clear about personal values] to 100 [feels extremely unclear about personal values].
    Time Frame
    immediately after the intervention
    Secondary Outcome Measure Information:
    Title
    Decisional Conflict
    Description
    Decisional Conflict Scale (16-item). Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 16; and c) multiplied by 25. Scores range from 0 [no decisional conflict] to 100 [extremely high decisional conflict].
    Time Frame
    immediately after the intervention
    Title
    % of patients with preference to undergo PSA screening (screening intention; questionnaire)
    Description
    Intention to undergo prostate cancer screening with PSA: questionnaire - single question about intention to be screened with PSA, using a 5 point-Likert scale (ranging from "strongly disagree" to "strongly agree"; intention to undergo PSA screening will be considered positive if the respondent replies with "agree" or "strongly agree"). % of patients with preference to undergo PSA screening.
    Time Frame
    before and immediately after the intervention
    Title
    % of patients who underwent PSA screening (questionnaire)
    Description
    Self-reported PSA screening. Questionnaire - single question. Men will report wether they have or have not underwent PSA screening after the intervention. % of patients who underwent PSA screening
    Time Frame
    6 months after the intervention

    10. Eligibility

    Sex
    Male
    Gender Based
    Yes
    Gender Eligibility Description
    the intervention's purpose is to support men's prostate cancer screening decision
    Minimum Age & Unit of Time
    50 Years
    Maximum Age & Unit of Time
    69 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: adult men (50 - 69 years); men with average risk for prostate cancer; willing and able to provide written informed consent. Exclusion Criteria: unable to understand written Portuguese.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Sofia Baptista, MD
    Phone
    00351910357362
    Email
    sofiatbaptista@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    António Soares, PhD
    Phone
    00351225513622
    Email
    ajasoares@cintesis.eu
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Sofia Baptista, MD
    Organizational Affiliation
    Universidade do Porto
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    Data will be made available on request
    Citations:
    PubMed Identifier
    32349746
    Citation
    Baptista S, Heleno B, Teixeira A, Taylor KL, Martins C. Comparison of explicit values clarification method (VCM), implicit VCM and no VCM decision aids for men considering prostate cancer screening: protocol of a randomized trial. BMC Med Inform Decis Mak. 2020 Apr 29;20(1):78. doi: 10.1186/s12911-020-1094-3.
    Results Reference
    derived

    Learn more about this trial

    Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening

    We'll reach out to this number within 24 hrs